These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31959424)

  • 1. Women who received varicella vaccine versus natural infection have different long-term T cell immunity but similar antibody levels.
    Tourtelot E; Quataert S; Glantz JC; Perlis L; Muthukrishnan G; Mosmann T
    Vaccine; 2020 Feb; 38(7):1581-1585. PubMed ID: 31959424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.
    Bianchi FP; Tafuri S; Larocca AMV; Germinario CA; Stefanizzi P
    BMC Infect Dis; 2021 May; 21(1):475. PubMed ID: 34034659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
    Kho MM; Zuijderwijk JM; van der Eijk AA; de Kuiper R; Boer-Verschragen MJ; Weimar W; van Besouw NM
    Vaccine; 2017 Jan; 35(1):71-76. PubMed ID: 27899225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella immunity in vaccinated healthcare workers.
    Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
    J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine.
    Perciani CT; Jaoko W; Walmsley S; Farah B; Mahmud SM; Ostrowski M; Anzala O; Team KI; MacDonald KS
    BMJ Open; 2017 Sep; 7(9):e017391. PubMed ID: 28939581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.
    Speth F; Hinze CH; Andel S; Mertens T; Haas JP
    Pediatr Rheumatol Online J; 2018 Mar; 16(1):15. PubMed ID: 29499726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune response of a varicella vaccine following simultaneous DTaP and VZV vaccination.
    Habermehl P; Lignitz A; Knuf M; Schmitt HJ; Slaoui M; Zepp F
    Vaccine; 1999 Feb; 17(7-8):669-74. PubMed ID: 10067672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment.
    Groot N; Pileggi G; Sandoval CB; Grein I; Berbers G; Ferriani VPL; Wulffraat N; de Roock S
    Vaccine; 2017 May; 35(21):2818-2822. PubMed ID: 28412076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.
    Prelog M; Schönlaub J; Jeller V; Almanzar G; Höfner K; Gruber S; Eiwegger T; Würzner R
    Vaccine; 2013 May; 31(20):2420-6. PubMed ID: 23583889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine.
    Terada K; Niizuma T; Ogita S; Kataoka N
    Vaccine; 2002 Nov; 20(31-32):3638-43. PubMed ID: 12399190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella zoster virus immunity in multinational health care workers of a Saudi Arabian hospital.
    Almuneef M; Dillon J; Abbas MF; Memish Z
    Am J Infect Control; 2003 Oct; 31(6):375-81. PubMed ID: 14608306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
    Barbosa CM; Terreri MT; Rosário PO; de Moraes-Pinto MI; Silva CA; Hilário MO
    Clin Exp Rheumatol; 2012; 30(5):791-8. PubMed ID: 22935227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
    Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
    Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different levels of humoral and cellular immunity to varicella-zoster virus in seropositive healthcare workers.
    Kang CK; Chang E; Jung J; Lee E; Song KH; Choe PG; Bang JH; Kim ES; Park SW; Kim HB; Kim NJ; Park WB; Oh MD
    J Infect Public Health; 2022 Jul; 15(7):734-738. PubMed ID: 35689946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.